This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jens Peter Brandt: Innovator in Pharmaceutical Chemistry
Introduction
Jens Peter Brandt is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work is characterized by a focus on improving treatments for various diseases.
Latest Patents
Jens Peter Brandt holds 1 patent related to amido heteroaromatic compounds. This patent encompasses compounds of Formula (I) and their pharmaceutically acceptable salts. The specification details processes and intermediates used for their preparation, as well as pharmaceutical compositions containing these compounds. Notably, these compounds are utilized in the treatment of diseases such as liver disease.
Career Highlights
Brandt is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to engage in cutting-edge research and development, contributing to the advancement of healthcare solutions. His expertise in pharmaceutical chemistry has positioned him as a valuable asset within the organization.
Collaborations
Throughout his career, Jens Peter Brandt has collaborated with esteemed colleagues, including Daniel Tor Pettersen and Stéphanie Marcelle Gueret. These collaborations have fostered innovation and have been instrumental in the successful development of new pharmaceutical compounds.
Conclusion
Jens Peter Brandt's contributions to pharmaceutical chemistry and his innovative work on amido heteroaromatic compounds highlight his importance in the field. His ongoing efforts at AstraZeneca AB continue to pave the way for advancements in medical treatments.